Dianne L. DeCamp - Concepedia

Author

Dianne L. DeCamp

The University of Texas Southwestern Medical Center

Also Known As

D L DeCamp, D. DECAMP, D. DeCamp, D. L. DECAMP, D. L. DeCamp, D.L. DeCamp, DIANNE L. DECAMP, DIANNE L. DeCAMP, Dianne DeCamp, Dianne Decamp

Publications

3.6K

Citations

H-Index

Concepts

All Affiliations

The University of Texas Southwestern Medical Center University of California, San Francisco California Institute of Technology W.E. Upjohn Institute for Employment Research University of Delaware

About

Dianne L. DeCamp is an author at The University of Texas Southwestern Medical Center specializing in medicine, natural sciences, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	14	1.6K
2	Natural Sciences	12	12	2.4K
3	Biochemistry	11	11	2.4K
4	Biomolecular Engineering	6	6	1.8K
5	Engineering	1	1	949

Dianne L. DeCamp

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
Inhibition of the HIV-1 protease by fullerene derivatives: model building studies and experimental verification Simon H. Friedman, Dianne L. DeCamp, Rint P. Sijbesma, Journal of the American Chemical Society EngineeringChemical AnalysisFullerene DerivativesOrganic ChemistryChemistry	1993	949
Synthesis of a fullerene derivative for the inhibition of HIV enzymes Rint P. Sijbesma, G. Srdanov, Fred Wudl, Journal of the American Chemical Society Pharmaceutical ScienceAltmetric Attention ScoreOrganic ChemistryChemistryHiv Enzymes	1993	444
2D Differential In-gel Electrophoresis for the Identification of Esophageal Scans Cell Cancer-specific Protein Markers Ge Zhou, Hongmei Li, Dianne L. DeCamp, Molecular & Cellular Proteomics	2002	388
Use of a cAMP BRET Sensor to Characterize a Novel Regulation of cAMP by the Sphingosine 1-Phosphate/G13 Pathway Lily I. Jiang, Julie Collins, Richard M. Davis, Journal of Biological Chemistry Camp Bret SensorMolecular BiologyCell DifferentiationCellular PhysiologyCamp Sensor	2007	343
Structure-based design of nonpeptide inhibitors specific for the human immunodeficiency virus 1 protease. Renée L. DesJarlais, George Seibel, Irwin D. Kuntz, Proceedings of the National Academy of Sciences Crystal StructureMolecular BiologyAntiviral DrugChemical BiologyMedicinal Chemistry	1990	254
Structure of a non-peptide inhibitor complexed with HIV-1 protease. Developing a cycle of structure-based drug design Earl Rutenber, Eric B. Fauman, Robert J. Keenan, Journal of Biological Chemistry Peptide EngineeringNon-peptide InhibitorType 1Medicinal ChemistryHiv-1 Protease	1993	123
A targeted mass spectrometric analysis of phosphatidylinositol phosphate species Stephen Milne, Pavlina T. Ivanova, Dianne L. DeCamp, Journal of Lipid Research	2005	116
Smoothened Activates Gαi-mediated Signaling in Frog Melanophores Dianne L. DeCamp, Teresa Thompson, Frédéric J. de Sauvage, Journal of Biological Chemistry	2000	102
Specificity and inhibition of proteases from human immunodeficiency viruses 1 and 2. A G Tomasselli, John O. Hui, T K Sawyer, Journal of Biological Chemistry ImmunologyMolecular BiologyAntiviral DrugEnzymatic ModificationHuman Immunodeficiency	1990	100
Selective Mutations in Cloned and Expressed α-Macroglobulin Receptor Binding Fragment Alter Binding to Either the α2-Macroglobulin Signaling Receptor or the Low Density Lipoprotein Receptor-related Protein/α2-Macroglobulin Receptor Gayle C. Howard, Yuko Yamaguchi, Uma Kant Misra, Journal of Biological Chemistry	1996	59

Page 1